Intranasal Esketamine (Spravato<sup>TM</sup>) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant.

Rebecca Bahr, Alicia Quirós López, Jose A Rey

PubMed · 2019 · 101 citations · 17 references

Full text

Open access

Concepts

Abstract

Intranasal esketamine for treatment-resistant depression.

References

17